October 2022
1. TAYLOR SM, Korwa S, Wu A, Gree CL, et al
   Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
   PLoS Med. 2022;19:e1004104.
   

   >> Share

   
   January 2022
2. PHYO AP, Dahal P, Mayxay M, Ashley EA, et al
   Clinical impact of vivax malaria: A collection review.
   PLoS Med. 2022;19:e1003890.
   

   >> Share

   
   June 2021
3. DEVINE A, Battle KE, Meagher N, Howes RE, et al
   Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
   PLoS Med. 2021;18:e1003614.
   

   >> Share

   
   April 2021
4. LEY B, Alam MS, Kibria MG, Marfurt J, et al
   Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case-control data from Bangladesh.
   PLoS Med. 2021;18:e1003576.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share